« Back
Home /
PPP1R13L Polyclonal Antibody

PPP1R13L Polyclonal Antibody

Item no.	E-AB-15724-120
Manufacturer	Elabscience
Amount	120 uL
Quantity options	120 uL 20 uL 200 uL 60 uL
Category	Oncology Antibodies Immunohistochemistry Western Blot ELISA Cardiovascular Research Ischemia & Reperfusion Injury Primary Antibodies By Organ Lung Cancer Bladder Cancer Breast Cancer
Type	Antibody Polyclonal
Applications	WB, IHC
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host	Rabbit
Isotype	IgG
Conjugate/Tag	Unconjugated
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	IASPP, inhibitor of apoptosis stimulating protein of p53, Inhibitor of ASPP protein, NFkB interacting protein 1, NKIP1, PPP1R13B-like protein, PPP1R13L, Protein iASPP, protein phosphatase 1 regulatory (inhibitor) subunit 13 like, RAI, RelA-associated inhibitor
Similar products	IASPP, PPP1R13L, NKIP1, RAI, NFkB interacting protein 1, RelA-associated inhibitor, inhibitor of apoptosis stimulating protein of p53, Inhibitor of ASPP protein, PPP1R13B-like protein, Protein iASPP, protein phosphatase 1 regulatory (inhibitor) subunit 13 like
Shipping condition	Cool pack
Hazard information	Comply with cargo safety certificate
Available
Manufacturer - Category	Primary Antibodies
Manufacturer - Targets	PPP1R13L
Shipping Temperature	The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions	Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight	89kDa
Research Areas	Cancer, Cell Biology, Epigenetics and Nuclear Signaling
Background	RelA-associated inhibitor is a protein that in humans is encoded by the PPP1R13L gene. Regulator that plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. Blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. Also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis. Interacts with RELA NF-kappa-B subunit and with SP1 via its C-terminus part. Interacts with p53/TP53, TP63 and TP73.
Concentration	0.6 mg/mL
Buffer	PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method	Affinity purification
Recommended Dilution	WB 1:500-1:2000; IHC 1:50-1:200
Santa Cruz #	sc-74941, sc-74942, sc-133686
Abbreviation	PPP1R13L
Clonality	Polyclonal
Immunogen	Synthetic peptide of human PPP1R13L
Category ID III	Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 120 uL

available

Delivery expected until 7/10/2025

Express Delivery: Save 17 days

Compare

Add to wishlist

Recommend by mail